Investing.com - UnitedHealth (NYSE: UNH) reported second quarter EPS of $6.80, $0.13 better than the analyst estimate of $6.67. Revenue for the quarter came in at $98.9B versus the consensus estimate of $98.72B.
Guidance
UnitedHealth sees FY 2024 EPS of $27.50-$28.00 versus the analyst consensus of $27.59.
UnitedHealth's stock price closed at $515.40. It is up 4.51% in the last 3 months and up 6.47% in the last 12 months.
UnitedHealth saw 2 positive EPS revisions and 18 negative EPS revisions in the last 90 days. See UnitedHealth's stock price’s past reactions to earnings here.
According to InvestingPro, UnitedHealth's Financial Health score is "great performance".
Check out UnitedHealth's recent earnings performance, and UnitedHealth's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar